BioAmber Inc fka BIOAQ

[iron-eagle]

Only 2 days left in the 12 month testing period for a Section 338 transaction since the Visolis transaction closed on Oct. 22, 2018. We’ve already seen the asset note cancellation as the Visolis transaction was funded through LCYT and LCYT shareholders received a dividend totaling roughly that amount which is waaaaaaaay to much for a regular dividend given the stock price and value of LCYT. Read up on Section 338 especially those paragraphs on a “Transaction Within Qualified Stock Purchase”. I hope they have controlling interest by now. If not they will have to move the price either way down to shake or way up to entice. Move it up; move it down. Not a chance you’re getting any of mine either way.


https://www.thetaxadviser.com/issues/2016/nov/transaction-pursuant-qualified-stock-purchase-treated-as-distribution-in-liquidation.html